Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein
about
NadA, a novel vaccine candidate of Neisseria meningitidisGenomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5.Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.Update on meningococcal disease with emphasis on pathogenesis and clinical managementHumoral immune responses to Neisseria meningitidis in children.Cellular immune responses to Neisseria meningitidis in childrenHuman opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorBDistribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidisOuter membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutantConstruction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands.The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membraneDomain exchange at the 3' end of the gene encoding the fratricide meningococcal two-partner secretion protein A.Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in NorwayAntigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design.Molecular characterization of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidisHuman antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineSpecificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccineImpact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayPCR of peripheral blood for diagnosis of meningococcal diseasePCR-single-stranded confirmational polymorphism analysis for non-culture-based subtyping of meningococcal strains in clinical specimens.Current status of meningococcal group B vaccine candidates: capsular or noncapsular?Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Mu-like Prophage in serogroup B Neisseria meningitidis coding for surface-exposed antigensHighly conserved Neisseria meningitidis surface protein confers protection against experimental infection.Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.Two-partner secretion systems of Neisseria meningitidis associated with invasive clonal complexes.
P2860
Q24675323-D61797C3-79C0-415B-BF96-942DD5DF4484Q30374765-558209C6-B9AF-414D-8179-76C5EF8E1B76Q33610780-D49C8089-3430-4CD9-B1FA-AEB4331644A6Q33812435-0770A5B5-50E4-4BB4-8B24-EA49A4F70135Q33867340-7FA6CD31-BF99-4A33-BFD8-A47A11C5AE8CQ33867356-7E8AF90F-5982-4EDC-B787-5D3F81B7F12FQ33867635-B879E49E-2D08-44EE-B796-B3006A8685EAQ33969625-43F9D693-754D-44E4-8225-ABEF201CA956Q33973163-22886C32-6A8A-495A-BE9D-39CB5CE64EABQ34003805-C179378D-BD99-436D-9E5A-3BBD8D5879F3Q34085394-1E14A438-46D1-4195-B764-21ADE6202608Q34516060-FEA8A736-3045-4E62-B756-0647F1491F2CQ34720425-FA809158-F271-4D50-9A96-8465630F79C3Q34746633-E4085A44-7F50-498E-A560-90CEB8A016DAQ34985648-99D48CE6-92C1-42D6-905C-8787EAF388D8Q34987045-9E0562AE-CC6B-46BF-8557-53F19A2ABB2DQ35224452-B184EC4F-E158-4CE7-9E8F-CA85EF6F2CCEQ35227153-EC981B69-4218-4F24-A64C-93A9028622CBQ35446808-7925E06B-99CB-4AAA-AFB3-50AA51757F64Q35454550-983B1449-6C73-40BC-9D30-9AE420D6A74BQ35506194-F5871F34-8842-4900-9CFA-D85A3F640605Q35560420-FD771052-F9E7-4908-A9B3-D6D6E7E6C318Q35922195-F6E564E2-F8F6-4CD9-8D53-DF82DFCE1278Q36313615-455517B1-B96F-475A-B444-0B9600E5473CQ36534641-0BEE0BD8-7F7C-41EF-BC7C-13309FB28858Q36545201-E96D0751-6405-4E06-90DC-9A2D91CF03B0Q36642138-CC851A19-8D84-4F25-AF53-BCBFC65C2256Q37058833-EFADFAE4-F8A4-48D8-A679-8500EF418841Q39519516-3C521E52-6DBF-4B6A-9572-EE8574180918Q41966979-30E60971-F8E2-40BD-919D-3CECEFE23401Q41971192-A236935D-6FB4-45DE-81E7-D3219E57D11EQ42664149-187E6509-2986-4202-BDA0-1C011DEE365B
P2860
Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Construction of a multivalent ...... class 1 outer membrane protein
@en
type
label
Construction of a multivalent ...... class 1 outer membrane protein
@en
prefLabel
Construction of a multivalent ...... class 1 outer membrane protein
@en
P2860
P1476
Construction of a multivalent ...... class 1 outer membrane protein
@en
P2093
Poolman JT
Van Der Ley P
P2860
P304
P407
P577
1992-08-01T00:00:00Z